| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1053-2498(00)00137-6 |
| P698 | PubMed publication ID | 10967264 |
| P2093 | author name string | Baldwin WM 3rd | |
| Qian Z | |||
| Hruban RH | |||
| Ota H | |||
| Sanfilippo F | |||
| Samaniego M | |||
| Wasowska B | |||
| P2860 | cites work | C5a-induced expression of P-selectin in endothelial cells | Q24633672 |
| Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation | Q34218574 | ||
| Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease | Q34275196 | ||
| Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation | Q35763398 | ||
| C6 produced by macrophages contributes to cardiac allograft rejection | Q35788306 | ||
| Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells | Q36362882 | ||
| Complement-mediated regulation of tissue factor activity in endothelium | Q36365648 | ||
| Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement | Q36366602 | ||
| The response of human platelets to activated components of the complement system | Q36845198 | ||
| Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation | Q36876002 | ||
| Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion | Q37051852 | ||
| Activated platelets signal chemokine synthesis by human monocytes | Q37353355 | ||
| Deleterious effects of complement activation on the lungs during extracorporeal circulation and its inhibition by FUT-175. | Q38660793 | ||
| Mononuclear phagocytes have the potential to synthesize the complete functional complement system | Q39643657 | ||
| Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells | Q40304477 | ||
| Transcriptional regulation of complement genes | Q40444867 | ||
| Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes | Q40794415 | ||
| Complement biosynthesis by mononuclear phagocytes | Q40804719 | ||
| Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation? | Q41268156 | ||
| Extrahepatic complement biosynthesis: where, when and why? | Q41331539 | ||
| The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity | Q41923727 | ||
| Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients | Q44024770 | ||
| Molecular basis of complement activation in ischemic myocardium: identification of specific molecules of mitochondrial origin that bind human C1q and fix complement | Q45100450 | ||
| Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft. | Q46510709 | ||
| Effects of explosive brain death on cytokine activation of peripheral organs in the rat. | Q47842738 | ||
| Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy | Q47957724 | ||
| Ultrastructure changes associated with brain death in the human donor heart | Q48821120 | ||
| Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines | Q48942611 | ||
| The identification of allo- and auto-lymphocytotoxic antibodies in serum, in the presence of rabbit antithymocyte globulin. | Q54392118 | ||
| Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways | Q67492759 | ||
| IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival | Q67531312 | ||
| Mild renal ischemia activates primed neutrophils to cause acute renal failure | Q67560088 | ||
| Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection | Q67773387 | ||
| Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol | Q68091180 | ||
| Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis | Q68856319 | ||
| Association of rheumatoid factors in renal transplant recipients with cytomegalovirus infection and not with rejection | Q70177273 | ||
| Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I | Q70911138 | ||
| Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema | Q71157326 | ||
| Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results | Q71474638 | ||
| Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients | Q71653212 | ||
| Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function | Q71665022 | ||
| Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation | Q71883090 | ||
| Capillary deposition of C4d complement fragment and early renal graft loss | Q72791721 | ||
| Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion | Q73047646 | ||
| Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies | Q73100253 | ||
| Complement C6 and C2 biosynthesis in syngeneic PVG/c- and PVG/c+ rat strains | Q73830717 | ||
| Influence of complement on the allospecific antibody response to a primary vascularized organ graft | Q73933710 | ||
| Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface | Q74222818 | ||
| Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion | Q74310898 | ||
| Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries | Q74554230 | ||
| In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients | Q74602297 | ||
| Human heart generates complement proteins that are upregulated and activated after myocardial infarction | Q77426372 | ||
| Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts | Q77552218 | ||
| Prevalence of HLA sensitization in female apheresis donors | Q77909820 | ||
| Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation | Q78199173 | ||
| mRNA expression of complement components and regulators in rat arterial smooth muscle cells | Q78238635 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 723-730 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | The Journal of Heart and Lung Transplantation | Q2364382 |
| P1476 | title | Complement as a mediator of vascular inflammation and activation in allografts | |
| P478 | volume | 19 |
| Q73667651 | Alloantibodies restore cardiac allograft rejection to IgKO mice |
| Q34786150 | Antibody-mediated activation of the classical complement pathway in xenograft rejection |
| Q35691658 | Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. |
| Q35666593 | Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection |
| Q39923372 | CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants |
| Q38080874 | Complement-mediated microvascular injury leads to chronic rejection |
| Q64246062 | Effects of Caloric Restriction with Protein Supplementation on Plasma Protein Profiles in Middle-Aged Women with Metabolic Syndrome-A Preliminary Open Study |
| Q53328600 | Microvascular integrity plays an important role for graft survival after experimental skin transplantation. |
| Q37286553 | Role of anti-vimentin antibodies in allograft rejection |
| Q73667757 | Terminal complement proteins in mediating processes of accelerated graft arteriosclerosis in cardiac transplants |
| Q34567289 | The endothelium in clinical cardiac transplantation |
| Q35223952 | The link between major histocompatibility complex antibodies and cell proliferation |
Search more.